Medtronic (MDT)
(Delayed Data from NYSE)
$89.34 USD
-0.90 (-1.00%)
Updated Aug 1, 2025 03:59 PM ET
After-Market: $89.29 -0.05 (-0.06%) 7:58 PM ET
4-Sell of 5 4
C Value B Growth D Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
MDT 89.34 -0.90(-1.00%)
Will MDT be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for MDT based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for MDT
Medtronic (MDT) Stock Moves -1.05%: What You Should Know
Medtronic (MDT) Stock Sinks As Market Gains: What You Should Know
MDT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Should Franklin U.S. Low Volatility High Dividend Index ETF (LVHD) Be on Your Investing Radar?
Medtronic (MDT) Outpaces Stock Market Gains: What You Should Know
ISRG Stock Before Q2 Earnings Release: To Buy or Not to Buy?
Other News for MDT
Citadel Advisors LLC Increases Stake in NioCorp Developments Ltd
See Which Of The Latest 13F Filers Holds MDT
Medtronic: Growth Challenges Persist
Thermo Fisher Scientific Inc Sees Significant Reduction in Eaton Vance Worldwide Health ...
Bill Gates Took A Customer Support Shift At His Daughter's AI Startup — And Showed What Real Leadership Looks Like